Verastem Inc (VSTM) - News Archive

Verastem Inc (NASDAQ: VSTM) has experienced a rollercoaster ride in the stock market recently, prompting investors and analysts to closely examine the reasons behind the company s volatile share performance. This articl...

Pomerantz LLP, a renowned law firm specializing in securities litigation, has recently announced that it is investigating claims on behalf of investors of Verastem, Inc. This article examines the allegations against the...

Pomerantz Law Firm Sets Sights on Verastem, Inc. Amid Investor Concerns New York, May 28, 2024: In a significant development that has captured the attention of investors and legal analysts alike, Pomerantz LLP has annou...

Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial in Metastatic Pancreatic CancerBOSTON Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company dedicated to advancing novel therapies for can...

BOSTON Verastem Oncology (Nasdaq: VSTM), an innovative biopharmaceutical company dedicated to developing and advancing new medicines for cancer patients, today heralded the initial interim safety and efficacy results fr...

The new face of biopharmaceutical industry, Verastem Oncology, known for its dedication in revolutionizing cancer treatments, is stepping up in its game. As per official reports, it recently presented promising business...

Verastem Oncology, a renowned biopharmaceutical company dedicated to developing innovative treatments for cancer patients, has recently released its financial results for the first quarter of 2024. The company has also...